Cancer stem cells: Culprits in endocrine resistance and racial disparities in breast cancer outcomes
Author:
Funder
Consejo Nacional de Investigaciones Científicas y Técnicas
National Institutes of Health
Publisher
Elsevier BV
Subject
Cancer Research,Oncology
Reference120 articles.
1. Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer;Cheang;J. Natl. Canc. Inst.,2009
2. Differential effects of selective oestrogen receptor modulators (SERMs) tamoxifen, ospemifene and raloxifene on human osteoclasts in vitro;Michael;Br. J. Pharmacol.,2007
3. Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10-year analysis of the ATAC trial;Cuzick;Lancet Oncol.,2010
4. Fulvestrant-based combination therapy for second-line treatment of hormone receptor-positive advanced breast cancer;Sammons;Targeted Oncol.,2019
5. 20-Year risks of breast-cancer recurrence after stopping endocrine therapy at 5 years;Pan;N. Engl. J. Med.,2017
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Adipocyte-conditioned medium induces tamoxifen resistance by activating PI3K/Akt/mTOR pathway in estrogen receptor-positive breast cancer cells;Biochimica et Biophysica Acta (BBA) - Molecular Cell Research;2024-10
2. M2 macrophages predicted the prognosis of breast cancer by combing a novel immune cell signature and promoted cell migration and invasion of cancer cells <i>in vitro</i>;BIOCELL;2024
3. Small molecule inhibition of TFF3 overcomes tamoxifen resistance and enhances taxane efficacy in ER+ mammary carcinoma;Cancer Letters;2023-11
4. UCHL1 promotes cancer stemness in triple-negative breast cancer;Pathology - Research and Practice;2022-12
5. SETD8 induces stemness and epithelial–mesenchymal transition of pancreatic cancer cells by regulating ROR1 expression;Acta Biochimica et Biophysica Sinica;2021-10-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3